Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :


By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :


Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Khiron Life Sciences Corp. V.KHRN

Alternate Symbol(s):  KHRNF

"Khiron Life Sciences Corp is a Canada based company involved in cultivating, producing, and distributing THC (tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. Some of the potential uses for medicinal cannabis are disease treatment, pain relief, and disease prevention, including: treatment of epilepsy; slow cell damage in diabetes glaucoma, lower intraocular pressure; treatment of Tourette syndrome among others."

Latest Bullboard Posts

RE:KHRN - One to Watch

Bu11ish0NG0ld - 58 minutes ago

KHRN - One to Watch

Check it out
TimDaniels45 - 2 hours ago

RE:RE:RE:RE:RE:RE:Mexican President: Cannabis Legalization Not On Our Agenda

MSGHEREGUY - 3 hours ago

RE:RE:RE:RE:RE:Mexican President: Cannabis Legalization Not On Our Agenda

MSGHEREGUY - 11 hours ago

RE:RE:RE:RE:Mexican President: Cannabis Legalization Not On Our Agenda

MSGHEREGUY - 13 hours ago

RE:RE:RE:Mexican President: Cannabis Legalization Not On Our Agenda
trends242 - 1 day ago


Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.